National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

A consensus panel from the United States and Europe was convened recently to update and revise the 1997 consensus guidelines for the neuropathologic evaluation of Alzheimer's disease (AD) and other diseases of brain that are common in the elderly. The new guidelines recognize the pre‐clinical stage of AD, enhance the assessment of AD to include amyloid accumulation as well as neurofibrillary change and neuritic plaques, establish protocols for the neuropathologic assessment of Lewy body disease, vascular brain injury, hippocampal sclerosis, and TDP‐43 inclusions, and recommend standard approaches for the workup of cases and their clinico‐pathologic correlation.

• Publication year

  2012

• Venue

  Alzheimer's & Dementia

• Publication date

  2012-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jalz.2011.10.007PMID 22265587PMCID PMC3266529
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetics of Frontotemporal Lobar Degeneration

  2012cited by this paper
• TDP-43 in aging and Alzheimer's disease - a review.

  2011cited by this paper
• Hippocampal sclerosis in advanced age: clinical and pathological features.

  2011cited by this paper
• The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup

  2011cited by this paper
• The pathological process underlying Alzheimer’s disease in individuals under thirty

  2011cited by this paper
• The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association

  2011cited by this paper
• Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease

  2011cited by this paper
• TAR-DNA binding protein-43 and alterations in the hippocampus

  2011cited by this paper
• Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• Body mass index in midlife and late‐life as a risk factor for dementia: a meta‐analysis of prospective studies

  2011cited by this paper
• The Association Between Blood Pressure and Incident Alzheimer Disease: A Systematic Review and Meta-analysis

  2011cited by this paper
• Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer’s disease

  2011cited by this paper
• Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.

  2011cited by this paper
• Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years

  2011cited by this paper
• Neurodegenerative basis of age-related cognitive decline

  2010cited by this paper
• Amyloid load in nondemented brains correlates with APOE e4.

  2010cited by this paper
• Incidental Lewy body disease: Clinical comparison to a control cohort

  2010cited by this paper
• Vascular pathology in the aged human brain

  2010cited by this paper
• Where Vascular Meets Neurodegenerative Disease

  2010cited by this paper
• Is high homocysteine level a risk factor for cognitive decline in elderly? A systematic review, meta-analysis, and meta-regression.

  2010cited by this paper
• Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

  2010cited by this paper
• Cerebral Microinfarcts Associated with Severe Cerebral β‐Amyloid Angiopathy

  2010cited by this paper
• Genome-wide analysis of genetic loci associated with Alzheimer disease.

  2010cited by this paper
• Modeling the Association between 43 Different Clinical and Pathological Variables and the Severity of Cognitive Impairment in a Large Autopsy Cohort of Elderly Persons

  2010influential reference
• Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease.

  2010cited by this paper
• Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium.

  2009cited by this paper
• Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction

  2009cited by this paper
• Late-life dementias: does this unyielding global challenge require a broader view?

  2009cited by this paper
• Relative preservation of MMSE scores in autopsy-proven dementia with Lewy bodies

  2009cited by this paper
• The neuropathology of probable Alzheimer disease and mild cognitive impairment

  2009cited by this paper
• Phosphorylated TDP-43 in Alzheimer’s disease and dementia with Lewy bodies

  2009cited by this paper
• Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease.

  2009cited by this paper
• Different patterns of cerebral injury in dementia with or without diabetes.

  2009cited by this paper
• Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update

  2009cited by this paper
• Brain Lesions at Autopsy in Older Japanese-American Men as Related to Cognitive Impairment and Dementia in the Final Years of Life: A Summary Report from the Honolulu-Asia Aging Study

  2009cited by this paper
• Neuropathology in the Adult Changes in Thought Study: A Review

  2009cited by this paper
• Olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disorders

  2009influential reference
• Lewy Body Pathology in Normal Elderly Subjects

  2009cited by this paper
• Brains With Medial Temporal Lobe Neurofibrillary Tangles But No Neuritic Amyloid Plaques Are a Diagnostic Dilemma But May Have Pathogenetic Aspects Distinct From Alzheimer Disease

  2009cited by this paper
• Hippocampal sclerosis with four-repeat tau-positive round inclusions in the dentate gyrus: a new type of four-repeat tauopathy

  2009cited by this paper
• Cerebral amyloid angiopathy and its relationship to Alzheimer’s disease

  2008cited by this paper
• Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient.

  2008cited by this paper
• Staging of Neurofibrillary Pathology in Alzheimer's Disease: A Study of the BrainNet Europe Consortium

  2008influential reference
• Assessment of &agr;-Synuclein Pathology: A Study of the BrainNet Europe Consortium

  2008cited by this paper
• Evidence that incidental Lewy body disease is pre-symptomatic Parkinson’s disease

  2008cited by this paper
• The progression of pathology in longitudinally followed patients with Parkinson’s disease

  2008cited by this paper
• Understanding hippocampal sclerosis in the elderly: Epidemiology, characterization, and diagnostic issues

  2008cited by this paper
• Neuropathology of hippocampal sclerosis.

  2008cited by this paper
• Evaluation of alpha-synuclein immunohistochemical methods used by invited experts.

  2008cited by this paper
• TDP-43 immunoreactivity in anoxic, ischemic and neoplastic lesions of the central nervous system

  2008cited by this paper
• Olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disorders

  2008cited by this paper
• Reduced striatal tyrosine hydroxylase in incidental Lewy body disease

  2008cited by this paper
• Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations

  2008cited by this paper
• Pathological correlates of dementia in a longitudinal, population‐based sample of aging

  2007cited by this paper
• DLB and PDD boundary issues

  2007cited by this paper
• Clinicopathologic Correlations in a Large Alzheimer Disease Center Autopsy Cohort: Neuritic Plaques and Neurofibrillary Tangles "Do Count" When Staging Disease Severity

  2007cited by this paper
• TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease

  2007cited by this paper
• Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration

  2007cited by this paper
• Aβ Oligomers – a decade of discovery

  2007cited by this paper
• Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases

  2007influential reference
• Lewy body pathology in familial Alzheimer disease: evidence for disease- and mutation-specific pathologic phenotype.

  2006cited by this paper
• Cognitive impact of subcortical vascular and Alzheimer's disease pathology

  2006cited by this paper
• Alzheimer Disease With Amygdala Lewy Bodies: A Distinct Form of &agr;-Synucleinopathy

  2006cited by this paper
• Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry

  2006influential reference
• Interlaboratory Comparison of Assessments of Alzheimer Disease-Related Lesions: A Study of the BrainNet Europe Consortium

  2006cited by this paper
• National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards

  2006cited by this paper
• Circle of Willis atherosclerosis: association with Alzheimer’s disease, neuritic plaques and neurofibrillary tangles

  2006cited by this paper
• Vascular cognitive impairment

  2006cited by this paper
• Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases.

  2005cited by this paper
• Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium

  2005cited by this paper
• Most cases of dementia with hippocampal sclerosis may represent frontotemporal dementia

  2005cited by this paper
• Diagnosis and management of dementia with Lewy bodies

  2005cited by this paper
• Aβ deposition is associated with enhanced cortical α-synuclein lesions in Lewy body diseases

  2005cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004influential reference
• Lewy body-related alpha-synucleinopathy in aging.

  2004cited by this paper
• Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function.

  2004cited by this paper
• Most cases of dementia with hippocampal sclerosis may represent frontotemporal dementia

  2004cited by this paper
• Staging of brain pathology related to sporadic Parkinson's disease.

  2003cited by this paper
• Where Does Parkinson Disease Pathology Begin in the Brain?

  2002influential reference
• Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  2002cited by this paper
• Phases of Aβ-deposition in the human brain and its relevance for the development of AD

  2002influential reference
• When running a stop sign may be a good thing

  2001cited by this paper
• Tau isoform profile and phosphorylation state in dementia pugilistica recapitulate Alzheimer's disease

  2001cited by this paper
• Cerebral amyloid angiopathy: A microvascular link between parenchymal and vascular dementia?

  2001cited by this paper
• Different conformation of neuronal tau deposits distinguished by double immunofluorescence with AT8 and thiazin red combined with Gallyas method

  2001cited by this paper
• Sequence of Aβ‐Protein Deposition in the Human Medial Temporal Lobe

  2000cited by this paper
• “Preclinical” AD revisited

  2000cited by this paper
• Lewy Bodies in Alzheimer's Disease: A Neuropathological Review of 145 Cases Using α‐Synuclein Immunohistochemistry

  2000cited by this paper
• Neuropathologic Substrates of Ischemic Vascular Dementia

  2000cited by this paper
• Sequence of Abeta-protein deposition in the human medial temporal lobe.

  2000cited by this paper
• The Cholinergic Deficit Coincides with Aβ Deposition at the Earliest Histopathologic Stages of Alzheimer Disease

  2000cited by this paper
• Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease

  1999cited by this paper
• Assessment of the Pathological Stages of Alzheimer’s Disease in Thin Paraffin Sections: A Comparative Study

  1998cited by this paper
• Senile Dementia with Tangles (Tangle Predominant Form of Senile Dementia)

  1998cited by this paper
• A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1

  1998cited by this paper
• Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease.

  1998cited by this paper
• Cholinergic fibre loss associated with diffuse plaques in the non-demented elderly: the preclinical stage of Alzheimer’s disease?

  1997cited by this paper
• Frequency of stages of Alzheimer-related lesions in different age categories.

  1997cited by this paper

• Defining Alzheimer’s disease: stipulations and the ethics of diagnostic change

  2026cites this paper
• Association Between Longitudinal Rate of Change in CSF Biomarkers and Subsequent Tau PET Burden in Early Braak Stages

  2026cites this paper
• Angiotensin II–Stimulating Antihypertensive Medications and Dementia-Related Neuropathology

  2026cites this paper
• Advancing Theranostics in Alzheimer Disease: FDA Approval of Amyloid-β PET Drugs for Selection of Patients for Amyloid-β-Directed Therapies and Other Labeling Updates.

  2026cites this paper
• The role of astrocytes in Alzheimer's disease: Pathophysiology, biomarkers, and therapeutic potential

  2026cites this paper
• Integrative epigenomic landscape of Alzheimer’s Disease brains reveals oligodendrocyte molecular perturbations associated with tau

  2026cites this paper
• Imaging brain class I histone deacetylase changes in the Lewy body dementias and Parkinson’s disease

  2026cites this paper
• Conformation-specific monoclonal antibodies reveal early Tau structural intermediates in Alzheimer's disease.

  2026cites this paper
• Human hippocampal neurogenesis in adulthood, ageing and Alzheimer's disease.

  2026cites this paper
• Accuracy of clinical diagnosis in neurodegenerative diseases - a study of 455 autopsy cases

  2026cites this paper
• Postmortem Associations Between Alzheimer Disease Pathology and Plasma pTau217, GFAP, and NfL in AD and AD-Related Dementias.

  2026cites this paper
• Gray matter microstructure from in vivo diffusion magnetic resonance imaging reflects post mortem neuropathology severity and clinical progression of Alzheimer's disease

  2026cites this paper
• Brain network dynamics determine tau presence while regional vulnerability governs tau load in Alzheimer’s disease

  2026cites this paper
• Hyperphosphorylated tau and amyloid-β proteinopathy in people over age 50: Findings from the Lieber Institute for Brain Development Brain Donation Repository

  2026cites this paper
• Comparing Gallyas and AT8 staining for quantification of tau pathology in subregions of the human hippocampus.

  2026cites this paper
• Comprehensive profiling of Aβ40 and Aβ42 fibril‐interacting proteins reveals PRKCG as a drug‐targetable regulator of amyloidogenesis in Alzheimer's disease

  2026cites this paper
• Human brain prefrontal cortex proteomics identifies compromised energy metabolism and neuronal function in Schizophrenia

  2026cites this paper
• Incidence of altered proteins in the aging brain: Implications for biological diagnostic markers

  2026cites this paper
• Scanning ion conductance microscopy for living cell nanomechanics: principles, advances and applications.

  2026cites this paper
• Inflammation, Limbic White Matter Microstructure, and Clinical Symptoms in Retired American Football Players With Repetitive Head Impacts.

  2026cites this paper
• EPA/DHA-enriched AKO on Alleviating Age-Related Cognitive Impairment via Inhibiting Aβ Deposition, Neurofibrillary Tangles and Inflammation in SAMP8 Mice

  2026cites this paper
• A path to preventing cognitive impairment due to Alzheimer's disease: initiatives beginning in the USA.

  2026cites this paper
• Alterations in cerebrospinal fluid levels of myelin- and oligodendrocyte-related proteins in sporadic Creutzfeldt–Jakob disease

  2026cites this paper
• Preclinical amyloid pathology is associated with anxiety but not depression in cognitively normal older adults: Evidence for differential neuropsychiatric pathways

  2026cites this paper
• Spontaneous isomerization of tau is most prevalent in Alzheimer’s disease

  2026cites this paper
• Neuropathologic Profiles and Associated Cognitive Trajectories in Community-Living Older Adults

  2026cites this paper
• Amyloidosis of bridging veins is a pathologic feature of Alzheimer's disease.

  2026cites this paper
• Ultrastructural diversity and subcellular organization of nigral Lewy pathology in Parkinson’s disease

  2026cites this paper
• Salivary Gland Uptake on 18F‐Florbetaben PET Did Not Demonstrate Additional Diagnostic Value for Alzheimer's Disease

  2026cites this paper
• Alpha-synuclein seeding activity in postmortem tissues from patients with diffuse and isolated Lewy bodies

  2026cites this paper
• Associations of modifiable and non-modifiable risk factors with longitudinal white matter hyperintensities, amyloid-β and tau - a prospective cohort study

  2026cites this paper
• Identifying early changes in imaging, plasma, and digital cognitive biomarkers that correspond to Alzheimer's disease pathology in the presence of autopsy‐confirmed co‐pathologies

  2026cites this paper
• Brain‐peripheral proteome crosstalk in Alzheimer's disease with and without diabetes mellitus

  2026cites this paper
• Genome wide association study meta-analysis of neuropathologic lesions of Alzheimer's disease and related dementias in a multi-site autopsy cohort

  2026cites this paper
• Dyrk1a inhibition with the Novel Compound DYR533: A Cross-Disease Therapeutic Strategy Targeting Amyloidosis, Tau Pathogenesis, and Neuroinflammation

  2026cites this paper
• Rostral Associations of MRI Atrophy of the Amygdala and Entorhinal Cortex Across the AD Spectrum

  2026cites this paper
• Molecular signatures of resilience to Alzheimer's disease in neocortical layer 4 neurons.

  2026cites this paper
• Sex and APOE ε4 genotype modify risk factor associations with cerebral amyloid angiopathy: a multi-cohort autopsy study.

  2026cites this paper
• Elevated Na+/K+ Ratio in Alzheimer’s Disease: A Potential Biomarker for Braak Stage

  2026cites this paper
• Neuropathologic basis of quantitative susceptibility mapping in the substantia nigra: contributions of tau, pigmented neurons, and iron

  2026cites this paper
• A neurotoxic cryptic peptide arising from TDP-43-dependent cryptic splicing of PKN1.

  2026cites this paper
• Sex Differences in Amyloid Pathology by Race, Ancestry, and Apolipoprotein E ε4 in an Admixed Autopsy Sample.

  2026cites this paper
• Functional and structural retinal alterations in Alzheimer's disease: insights from photopic negative response (PhNR) and OCT-based analysis.

  2026cites this paper
• Associations between Structural Neuroimaging Markers and Neuropathology of Alzheimer's Disease.

  2026cites this paper
• Cardiovascular risk factors and vascular neuropathological findings in primary age-related tauopathy versus Alzheimer's disease.

  2026cites this paper
• Clinical study on gray matter volume reduction, gait disorders, and fall risk in patients with Alzheimer's disease.

  2026cites this paper
• The 2024 NIA-AA biological definition of Alzheimer's disease: linking biomarkers to clinical practice.

  2026cites this paper
• Microglial reactivity in the hippocampal CA2 is associated with advanced neuronal α-synucleinopathy

  2026cites this paper
• Incidental 18F-Flortaucipir Uptake in Pituitary Macroadenoma.

  2026cites this paper
• Gut-brain axis in health and brain disease.

  2026cites this paper
• A novel PSEN1 (p.Gln223Leu) variant associated with spastic paraparesis and early-onset Alzheimer's disease

  2026cites this paper
• Isomerized Aβ in the brain can distinguish the status of amyloidosis in the Alzheimer’s Disease spectrum

  2025cites this paper
• APOE deficiency inhibits amyloid-facilitated (A) tau pathology (T) and neurodegeneration (N), halting progressive ATN pathology in a preclinical model

  2025cites this paper
• Impact of chronic hyperglycemia and high-fat diet on Alzheimer’s disease-related pathology in CX3CR1 knockout mice

  2025cites this paper
• Lipid mediated formation of antiparallel aggregates in cerebral amyloid angiopathy

  2025cites this paper
• Interpreting Biomarker Test Results for Alzheimer Disease, Parkinson Disease and Other Neurodegenerative Diseases Without the Autopsy Gold Standard

  2025influential citation
• Pathological mechanisms of motor dysfunction in familial Danish dementia: insights from a knock-in rat model

  2025cites this paper
• Cerebral Amyloid Angiopathy Is Associated With Higher R2 Relaxation Rate: An MRI and Pathology Study

  2025cites this paper
• Clinicopathological Correlations of Neurodegenerative Diseases in the National Brain Biobank of Korea

  2025cites this paper
• Oral microbiota profile is related to cognitive status in centenarians: a clinical and biological study.

  2025cites this paper
• Layer‐Dependent Effect of Aβ‐Pathology on Cortical Microstructure With Ex Vivo Human Brain Diffusion MRI at 7 Tesla

  2025influential citation
• Common neuropathologic change drivers of hippocampal sclerosis of ageing

  2025cites this paper
• Glial changes and gene expression in Alzheimer's disease from snRNA-Seq and spatial transcriptomics

  2025cites this paper
• The Alzheimer's Disease Continuum - A New Diagnostic Approach.

  2025cites this paper
• Clinical and Neuropathological Evaluations of the New Brunswick Neurological Syndrome of Unknown Cause.

  2025cites this paper
• Differentiating Progressive Supranuclear Palsy and Corticobasal Syndrome: Insights from Cerebrospinal Fluid Biomarkers—A Narrative Review

  2025cites this paper
• Loss of the APP regulator RHBDL4 preserves memory in an Alzheimer’s disease mouse model

  2025cites this paper
• The Pathology, Alzheimer's and Related Dementias Study (PARDoS): Design and Characteristics of the First 4700+ Brazilian Participants

  2025cites this paper
• Microbial diversity and fitness in the gut–brain axis: influences on developmental risk for Alzheimer’s disease

  2025cites this paper
• Investigation of the mechanism of Buyang Huanwu decoction in improving learning and memory impairment in Alzheimer's disease mice based on lipidomics

  2025cites this paper
• Characterizing visual read tau‐PET‐negative participants with Alzheimer's disease dementia

  2025cites this paper
• Distinct patterns of cognitive traits in extreme old age and Alzheimer's disease

  2025cites this paper
• Growth associated protein 43 (GAP-43) predicts brain amyloidosis in Alzheimer’s dementia continuum: an [18 F] AV-45 study

  2025cites this paper
• Alzheimer mimicry: LATE and PART

  2025cites this paper
• Pathological Characterisation of Posterior Cortical Atrophy in Comparison With Amnestic Alzheimer's Disease

  2025cites this paper
• Elevated neuroinflammation, autoimmunity, and altered IgG glycosylation profile in the cerebral spinal fluid of severe COVID-19 patients.

  2025cites this paper
• The impact of arteriolosclerosis on cognitive impairment in decedents without severe dementia from the National Alzheimer's Coordinating Center

  2025cites this paper
• Fast Interneuron Dysfunction in Laminar Neural Mass Model Reproduces Alzheimer's Oscillatory Biomarkers

  2025cites this paper
• Quantification of perforant path fibers for early detection of Alzheimer's disease

  2025cites this paper
• Human skeletal muscle mitochondrial pathways are impacted by a neuropathologic diagnosis of Alzheimer's disease.

  2025cites this paper
• Loss of age-associated increase in m6A-modified RNA contributes to GABAergic dysregulation in Alzheimer's disease

  2025cites this paper
• Alzheimer's disease neuropathology and its estimation with fluid and imaging biomarkers

  2025influential citation
• Correlating hippocampal and amygdala volumes with neuropathological burden in Down syndrome and Alzheimer’s disease and related neurodegenerative pathologies using 7T postmortem MRI

  2025cites this paper
• Elucidating the mechanisms of Shenwu Capsule in improving the cognitive decline in aging based on the UPLC-Q-TOF-MS, network pharmacology, and experimental validation.

  2025cites this paper
• Enhanced social interaction protects cognition by preserving synapse numbers.

  2025cites this paper
• Differential Transcriptional Programs Reveal Modular Network Rearrangements Associated with Late-Onset Alzheimer’s Disease

  2025cites this paper
• Exploring epidemiological risk factors for cerebral amyloid angiopathy: Considerations for monoclonal antibody therapy in people with Alzheimer's disease

  2025cites this paper
• Parkinsonism in Alzheimer's disease without Lewy bodies in association with nigral neuron loss: A data‐driven clinicopathologic study

  2025cites this paper
• Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease

  2025cites this paper
• Recurrent patterns of widespread neuronal genomic damage shared by major neurodegenerative disorders

  2025cites this paper
• Comparing high and low amyloid producers in Alzheimer's disease: An in-depth analysis.

  2025cites this paper
• A practical overview of the use of amyloid-PET Centiloid values in clinical trials and research

  2025cites this paper
• Probe-dependent Proximity Profiling (ProPPr) Uncovers Similarities and Differences in Phospho-Tau-Associated Proteomes Between Tauopathies

  2025cites this paper
• Associations between neuropsychiatric symptoms and pathology in clinicopathologically defined Alzheimer's disease, Alzheimer's disease with Lewy bodies, and dementia with Lewy bodies

  2025cites this paper
• Morphological substrate of chronic schizophrenia in elderly patients: a clinicopathological study.

  2025cites this paper
• Cell Type-Specific Studies of Human Tissue for Investigation of the Molecular Cell Biology of Late-Onset Neurodegenerative Disease.

  2025cites this paper
• Genetic risk implicating endolysosomal network genes correlates with endolysosomal dysfunction across neural cell types in Alzheimer’s disease

  2025cites this paper
• Spliceosome protein alterations differentiate hubs of the default mode connectome during the progression of Alzheimer's disease

  2025cites this paper
• Differential senolytic inhibition of normal versus Aβ-associated cholinesterases: implications in aging and Alzheimer’s disease

  2025cites this paper
• Relation of Alzheimer's disease-related TDP-43 proteinopathy to metrics from diffusion tensor imaging (DTI) and neurite orientation dispersion and density imaging (NODDI).

  2025cites this paper